| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 10/10/2002 | WO2002057215A3 Sodium channel modulators |
| 10/10/2002 | WO2002053516A3 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 10/10/2002 | WO2001072728A9 Novel piperazine derivatives |
| 10/10/2002 | US20020147359 Neurokinin antagonist; antiinflammatory agents, antiallergens |
| 10/10/2002 | US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
| 10/10/2002 | US20020147336 Glucocorticoid receptor modulators |
| 10/10/2002 | US20020147193 Novel couplers for use in oxidative hair dyeing |
| 10/10/2002 | US20020147187 Antiproliferative agents; anticancer agents |
| 10/10/2002 | US20020147186 Side effect reduction |
| 10/10/2002 | US20020144361 Novel couplers for use in oxidative hair dyeing |
| 10/10/2002 | US20020144359 Derivatives of 2-aminophenol; providing good oxidative coloration of hair and for providing acceptable light fastness, selectivity, fastness to shampooing |
| 10/10/2002 | US20020144358 2-substituted-4-amino-phenol derivative compounds providing good oxidative coloration of hair and acceptable light fastness, fastness to shampooing and permanent wave treatment |
| 10/10/2002 | US20020144357 Benzene-1,4-diamine compounds having a weaker sensitization potential than p-phenylenediamine |
| 10/10/2002 | DE10116768A1 Hypoglycemic medicaments useful for treating type II diabetes contain new or known N-aroyl-N'-phenyl-urea derivatives which are glycogen phosphorylase a inhibitors |
| 10/10/2002 | DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant |
| 10/10/2002 | CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 10/09/2002 | EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/09/2002 | EP1246819A1 A method for the preparation of substituted benzene derivatives |
| 10/09/2002 | EP1246817A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 10/09/2002 | EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists |
| 10/09/2002 | EP1246795A2 Antibacterial agents |
| 10/09/2002 | EP1246790A1 Substituted 1 and 2 naphthol mannich bases |
| 10/09/2002 | EP1246625A2 Methods and compositions for mitigating pain using nitrate esters |
| 10/09/2002 | EP0882704B1 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives |
| 10/09/2002 | EP0874836B1 Sulfonamide inhibitors of matrix metalloproteinases |
| 10/09/2002 | CN1373765A Calcium complex of phosphorus contg. ethylenediamine derivs. |
| 10/09/2002 | CN1373754A Antibacterial agents |
| 10/09/2002 | CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 10/09/2002 | CN1373747A Process for making amine componds |
| 10/08/2002 | US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia, |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 10/08/2002 | US6462064 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
| 10/08/2002 | US6462056 Oxazolidines as 5-HT2A-antagonists |
| 10/08/2002 | US6462042 Tumor necrosis factor alpha converting enzyme inhibitors; inflammatory diseases, autoimmune diseases, cancer, cardio-vascular diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, neurodegeneration, alzheimer's disease, stroke |
| 10/08/2002 | CA2081766C Leukotriene b4 antagonists |
| 10/03/2002 | WO2002077609A2 Identification of compounds for the treatment or prevention of proliferative diseases |
| 10/03/2002 | WO2002076968A1 Malonates as inhibitors of the ice/ced-6 family of cysteine proteases |
| 10/03/2002 | WO2002076965A1 Non peptide mimetics based on the active sequence s42fllr46 of the thrombin receptor for the treatment of thrombosis and cancer |
| 10/03/2002 | WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 10/03/2002 | WO2002076947A1 Mch antagonists and their use in the treatment of obesity |
| 10/03/2002 | WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity |
| 10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/03/2002 | WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 10/03/2002 | WO2002076924A1 Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery |
| 10/03/2002 | WO2002076923A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds |
| 10/03/2002 | WO2002076918A1 NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT |
| 10/03/2002 | WO2002076916A1 Self-reducing anthraquinone compounds |
| 10/03/2002 | WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 10/03/2002 | WO2002076447A1 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 10/03/2002 | WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists |
| 10/03/2002 | WO2002062766A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 10/03/2002 | WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors) |
| 10/03/2002 | US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 10/03/2002 | US20020143056 As inactivator of antigen- specific T cells is useful in the prophylaxis or therapy of autoimmune diseases, disorders involving an autoimmune component or neoplastic diseases |
| 10/03/2002 | US20020143036 Pentafluorobenzenesulfonamides and analogs |
| 10/03/2002 | US20020143020 Novel piperazine derivatives |
| 10/03/2002 | US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders |
| 10/03/2002 | US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine |
| 10/03/2002 | US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92 |
| 10/03/2002 | US20020138919 Novel couplers for use in oxidative hair dyeing |
| 10/03/2002 | CA2443289A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds |
| 10/03/2002 | CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 10/03/2002 | CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/03/2002 | CA2410816A1 Nf-.kappa.b inhibitor containing substituted benzoic acid derivative as active ingredient |
| 10/02/2002 | EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV) |
| 10/02/2002 | EP1245561A1 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof |
| 10/02/2002 | EP1245550A1 Novel selective deacetylating agents |
| 10/02/2002 | EP1244643A1 Tryptase inhibitors |
| 10/02/2002 | EP1244624A1 Anthracene derivatives as anti-cancer agents |
| 10/02/2002 | EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 10/02/2002 | EP1244451A1 Substituted piperazine and piperidine calcium channel blockers |
| 10/02/2002 | EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 10/02/2002 | CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 10/02/2002 | CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 10/01/2002 | US6458957 α,α-dibromo-α-chloro-acetophenones as synthons |
| 10/01/2002 | US6458953 Valency platform molecules comprising carbamate linkages |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458806 Aryl alkenamides derivatives as MCP-1 antagonists |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated |
| 10/01/2002 | US6458781 Blockers calcium channel antagonists for strokes, brain disorders |
| 10/01/2002 | CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists |
| 09/26/2002 | WO2002074756A2 Urokinase inhibitors |
| 09/26/2002 | WO2002074755A1 Method of producing n-substituted 2,6-dialkyl morpholines |
| 09/26/2002 | WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same |
| 09/26/2002 | WO2002074740A1 Biguanide derivatives |
| 09/26/2002 | WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient |
| 09/26/2002 | WO2002034698A3 Phosgene-free process for preparing carbamates |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2002018334B1 Sodium channel modulators |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137974 Catalysis using phosphine oxide and sulfoxide compounds |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137774 Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 09/26/2002 | US20020137742 Benzenesulfonamide compounds |